Welcome to LookChem.com Sign In|Join Free

CAS

  • or

122536-76-9

Post Buying Request

122536-76-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

122536-76-9 Usage

Chemical Properties

White crystalline powder

Uses

(S)-3-(Boc-amino)pyrrolidine can be used as a building block to prepare: 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as potent inhibitors against EGFR tyrosine kinase. Aminopyrrolidine scaffolds for asymmetric Morita?Baylis-Hillman reaction. N-benzyl-3-sulfonamidopyrrolidines as potent bacterial cell division inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 122536-76-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,5,3 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 122536-76:
(8*1)+(7*2)+(6*2)+(5*5)+(4*3)+(3*6)+(2*7)+(1*6)=109
109 % 10 = 9
So 122536-76-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O2/c1-9(2,3)13-8(12)11-7-4-5-10-6-7/h7,10H,4-6H2,1-3H3,(H,11,12)/t7-/m0/s1

122536-76-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1172)  (3S)-(-)-3-(tert-Butoxycarbonylamino)pyrrolidine  >98.0%(GC)(T)

  • 122536-76-9

  • 5g

  • 1,150.00CNY

  • Detail
  • TCI America

  • (A1172)  (3S)-(-)-3-(tert-Butoxycarbonylamino)pyrrolidine  >98.0%(GC)(T)

  • 122536-76-9

  • 25g

  • 3,980.00CNY

  • Detail
  • Alfa Aesar

  • (H51729)  (S)-(-)-3-(Boc-amino)pyrrolidine, 98%   

  • 122536-76-9

  • 5g

  • 1048.0CNY

  • Detail
  • Alfa Aesar

  • (H51729)  (S)-(-)-3-(Boc-amino)pyrrolidine, 98%   

  • 122536-76-9

  • 25g

  • 4127.0CNY

  • Detail
  • Alfa Aesar

  • (L19693)  (S)-(-)-3-(Boc-amino)pyrrolidine, 99%, ee 99%   

  • 122536-76-9

  • 1g

  • 684.0CNY

  • Detail
  • Alfa Aesar

  • (L19693)  (S)-(-)-3-(Boc-amino)pyrrolidine, 99%, ee 99%   

  • 122536-76-9

  • 5g

  • 2297.0CNY

  • Detail
  • Aldrich

  • (52927)  (S)-3-(Boc-amino)pyrrolidine  ≥98.0% (TLC)

  • 122536-76-9

  • 52927-1G-F

  • 1,670.76CNY

  • Detail
  • Aldrich

  • (52927)  (S)-3-(Boc-amino)pyrrolidine  ≥98.0% (TLC)

  • 122536-76-9

  • 52927-5G-F

  • 5,769.27CNY

  • Detail

122536-76-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-3-(Boc-Amino)Pyrrolidine

1.2 Other means of identification

Product number -
Other names (S)-tert-Butyl pyrrolidin-3-ylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:122536-76-9 SDS

122536-76-9Relevant articles and documents

Synthesis and evaluation of novel ligands for the histamine H4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold

Gao, Ling-Jie,Schwed, J. Stephan,Weizel, Lilia,De Jonghe, Steven,Stark, Holger,Herdewijn, Piet

, p. 132 - 137 (2013/02/23)

Starting from a known H4R ligand based on a pyrimidine skeleton, a series of novel analogues based on a pyrrolo[2,3-d]pyrimidine scaffold have been prepared. Whereas the original pyrimidine congener shows good affinity at hH4R (Ki = 0.5 μM), its lacks selectivity with a K i value for the hH3R of 1 μM. Within the newly synthesized pyrrolo[2,3-d]pyrimidines, several congeners show Ki values of less than 1 μM at the hH4R and show a much improved selectivity profile. Therefore, these series represent an interesting starting point for the discovery of novel hH4R ligands.

STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES

-

Page/Page column 15, (2010/06/22)

This invention relates to dialdehyde or dinitrile compounds, which are useful for stereoselective synthesis of piperidine, pyrrolidine, and azepane derivatives.

Methods of treating insulin resistance syndrome and diabetes

-

, (2008/06/13)

This invention is directed to methods of treating insulin resistance syndrome and diabetes in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound derived from adenosine and analogues thereof, or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof, or a pharmaceutical composition comprising such compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 122536-76-9